Atlas Trials

Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

Clinical trial NCT00148837 · COMPLETED

Trial details

NCT number
NCT00148837
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C, ChronicFibrosis
Start date
2004-09-01
Primary completion
2008-12-01
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.